Compare Novartis AG (NVS) vs United States Natural Gas Fund (UNG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs United States Natural Gas Fund — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while United States Natural Gas Fund trades at $10.41. The key difference: Novartis AG pays a 3.17% dividend while United States Natural Gas Fund pays none, and Novartis AG is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.
| NVS | UNG | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Commodities - Energy |
52-Week High | $168.62 | $16.90 |
52-Week Low | $113.50 | $10.15 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About United States Natural Gas Fund
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →
